Suzhou Zelgen Biopharmaceuticals Co. Ltd.SSE: 688266

(688266)"Suzhou Zelgen Biopharmaceuticals Co., Ltd."Announcement on Voluntary Disclosure of Receipt of Milestone Payment under the Global Strategic Collaboration and License Option Agreement with AbbVie in respect of ZG006

· Issued by Suzhou Zelgen Biopharmaceuticals Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688266 ·

On 6ix: 6ix.com/news/688266suzhou-zelgen-biopharmaceuticals-co-ltdannouncement-on-voluntary-disclosure-of-receipt-of-milestone-payment-under-the-global-strategic-collaboration-and-license-option-agreement-with-abbvie-in-respect-of-zg006

Announcement on Voluntary Disclosure of Receipt of Milestone Payment under the Global Strategic Collaboration and License Option Agreement with AbbVie in respect of ZG006

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Suzhou Zelgen Biopharmaceuticals Co. Ltd. on 6ix

Story so far

Earlier from Suzhou Zelgen Biopharmaceuticals

All Suzhou Zelgen Biopharmaceuticals news releases